We are live on ! Find out more
WST icon

West Pharmaceutical

573 hedge funds and large institutions have $18.8B invested in West Pharmaceutical in 2020 Q3 according to their latest regulatory filings, with 101 funds opening new positions, 199 increasing their positions, 210 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

191% more call options, than puts

Call options by funds: $20M | Put options by funds: $6.87M

110% more first-time investments, than exits

New positions opened: 101 | Existing positions closed: 48

19% more capital invested

Capital invested by funds: $15.8B → $18.8B (+$2.98B)

10% more funds holding

Funds holding: 523573 (+50)

0% more funds holding in top 10

Funds holding in top 10: 99 (0)

5% less repeat investments, than reductions

Existing positions increased: 199 | Existing positions reduced: 210

1.26% less ownership

Funds ownership: 94.11%92.85% (-1.3%)

Holders
573
Holders Change
+50
Holders Change %
+9.56%
% of All Funds
11.56%
Holding in Top 10
9
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.18%
New
101
Increased
199
Reduced
210
Closed
48
Calls
$20M
Puts
$6.87M
Net Calls
+$13.1M
Net Calls Change
+$2.64M
Name Holding Trade Value Shares
Change
Change in
Stake
Kayne Anderson Rudnick Investment Management
51
Kayne Anderson Rudnick Investment Management
California
$64.3M +$3.9M +14,748 +7%
Lord, Abbett & Co
52
Lord, Abbett & Co
New Jersey
$59.1M -$8.74M -33,016 -13%
Morgan Stanley
53
Morgan Stanley
New York
$57.5M +$13.4M +50,807 +32%
IIP
54
Intermede Investment Partners
United Kingdom
$54.8M -$4.44M -16,772 -8%
Teacher Retirement System of Texas
55
Teacher Retirement System of Texas
Texas
$54.4M +$23.1M +87,221 +79%
RhumbLine Advisers
56
RhumbLine Advisers
Massachusetts
$53.1M -$7.32M -27,670 -13%
Bessemer Group
57
Bessemer Group
New Jersey
$52.9M -$54.6M -206,366 -52%
Skandinaviska Enskilda Banken (SEB)
58
Skandinaviska Enskilda Banken (SEB)
Sweden
$51.3M +$2.56M +9,688 +5%
Arrowstreet Capital
59
Arrowstreet Capital
Massachusetts
$51.3M +$42.9M +162,003 +661%
First Trust Advisors
60
First Trust Advisors
Illinois
$50.1M -$7.81M -29,497 -14%
Envestnet Asset Management
61
Envestnet Asset Management
Illinois
$48.8M -$439K -1,660 -0.9%
PPA
62
Parametric Portfolio Associates
Washington
$48.8M -$2.03M -7,662 -4%
California Public Employees Retirement System
63
California Public Employees Retirement System
California
$46.4M +$1.03M +3,904 +2%
Acadian Asset Management
64
Acadian Asset Management
Massachusetts
$45.8M +$4.37M +16,497 +11%
TD Asset Management
65
TD Asset Management
Ontario, Canada
$45.3M +$11.6M +43,718 +36%
Deutsche Bank
66
Deutsche Bank
Germany
$43M -$512K -1,934 -1%
Los Angeles Capital Management
67
Los Angeles Capital Management
California
$41.8M +$125K +474 +0.3%
New York State Common Retirement Fund
68
New York State Common Retirement Fund
New York
$39.4M +$1.42M +5,353 +4%
California State Teachers Retirement System (CalSTRS)
69
California State Teachers Retirement System (CalSTRS)
California
$37.9M +$1.82M +6,883 +5%
AQR Capital Management
70
AQR Capital Management
Connecticut
$37M +$5.57M +21,040 +18%
Mawer Investment Management
71
Mawer Investment Management
Alberta, Canada
$36.7M -$6.59M -24,885 -16%
William Blair & Company
72
William Blair & Company
Illinois
$34.9M -$539K -2,035 -2%
Lazard Asset Management
73
Lazard Asset Management
New York
$34.8M +$3.47M +13,095 +12%
Citigroup
74
Citigroup
New York
$34.8M -$7.4M -27,949 -18%
HSBC Holdings
75
HSBC Holdings
United Kingdom
$34.2M +$4.06M +15,348 +14%

WST Hedge Fund Activity: Q3 2020 in Review

573 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2020, worth a combined $18.8B — up 19% from $15.8B a quarter earlier.

Buyers outnumbered sellers: 101 funds opened new WST positions and 48 closed out — a net gain of 53 holders — while 199 added to existing stakes and 210 trimmed.

The largest buyer was Invesco, adding an estimated $123M. The largest seller was T. Rowe Price Associates, cutting an estimated $223M.

  • 573 institutional investors held West Pharmaceutical (WST) as of Q3 2020, up from 523 in Q2 2020.
  • Funds reported $18.8B of West Pharmaceutical stock for Q3 2020, up 19% quarter-over-quarter.
  • 101 funds opened new West Pharmaceutical positions in Q3 2020 and 48 closed out, a net change of +53 holders.
  • The largest West Pharmaceutical buyer in Q3 2020 was Invesco, an estimated $123M added.
  • The largest West Pharmaceutical seller in Q3 2020 was T. Rowe Price Associates, an estimated $223M sold.

Based on aggregated 13F filings for Q3 2020.